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George E Davis Jr* and Walter E LowellAbstract
Background: Published research has shown that month-of-birth variations modulate the incidence of adult human
diseases. This article explores diabetes type 2 as one of those diseases. This study uses the death records of
approximately 829,000 diabetics (approximately 90% were type-2) born before the year 1945 (and dying between
1979 and 2005) to show that variations in adult lifespan vary with ultraviolet radiation (UVR) at solar cycle peaks
(MAX, approximately a three-year period) with less at non-peaks (MIN, approximately an eight-year period). The
MAX minus MIN (in years) was our measure of sensitivity (for example, responsiveness) to long-term variations in UVR.
Results: Diabetics were less sensitive than non-diabetics, and ethnic minorities were more sensitive than whites.
Diabetic males gained 6.1 years, and females 2.3 years over non-diabetics, with diabetic males gaining an average of
3.8 years over diabetic females. Most variation in lifespan occurred in those conceived around the seasonal equinoxes,
suggesting that the human epigenome at conception is especially influenced by rapid variation in UVR. With rapidly
decreasing UVR at conception, lifespan decreased in the better-nourished, white, female diabetic population.
Conclusions: Rapidly changing UVR at the equinoxes modulates the expression of an epigenome involving the
conservation of energy, a mechanism especially canalized in women. Decreasing UVR at conception and early
gestation stimulates energy conservation in persons we consider ‘diabetic’ in today’s environment of caloric surfeit. In
the late 19th and early 20th centuries ethnic minorities had poorer nutrition, laborious work, and leaner bodies, and in
that environment a calorie-conserving epigenome was a survival advantage. Ethnic minorities with a similar
epigenome lived long enough to express diabetes as we define it today and exceeded the lifespan of their non-
diabetic contemporaries, while that epigenome in diabetics in the nutritional environment of today is detrimental to
lifespan.
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conceptionBackground
Diabetes is a manifestation of the failure of the body to
manage carbohydrate intake with aging and increased
body weight. Over the past forty years there has been a
progressive decrease in the defined upper limits of nor-
mal for fasting blood glucose categorizing more persons
as diabetic, but even considering this changing diagnos-
tic threshold there is a worldwide increase in the inci-
dence and prevalence of diabetes mellitus, particularly
type-2 diabetes [1-3]. Epigenetic mechanisms are likely* Correspondence: georgedavi@gmail.com
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distribution, and reproduction in any mediuminvolved, especially in the third world where obesity is a
major, but not the only factor [4]. There are a wide
variety of potential modulators of the human epigenome,
which can be modified through methylation, X-
inactivation, maternal imprinting, and microRNAs, as
well as by environmental chemicals, toxins, caloric in-
take and dietary sugars [5-9]. In type-2 diabetes the early
effects of maternal nutrition and exposure to carbohy-
drates may ‘set’ a course for adult disease [10-15]. Stud-
ies report that the nutrition of grandparents has been
shown to affect future generations, particularly the male
probands [8,16-19]. However, the most important modify-
ing factors in type-2 diabetes in adults are excess caloricntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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stitutes of Health Research estimates that a North Ameri-
can child born in the year 2000 has one chance in three of
being diabetic in his/her lifetime. The lifetime expenses
associated with this diagnosis are considerable, and with a
‘baby boomer’ generation manifesting more diabetes as it
ages, the societal cost for this metabolic disease in the
United States will triple by the year 2034 [20,21].
Although type-2 diabetes is pathological in our current
environment of surfeit, we hypothesize the disease is a
manifestation of an ancient survival mechanism, for ex-
ample, a manifestation of the ability of the human spe-
cies to conservatively store and efficiently metabolize
calories in times of hardship. In addition, we propose
that those afflicted with type-2 diabetes are manifesting
the epigenetic changes due to lifestyle (insufficient exer-
cise, excess sugars), as well as by aging and genetic
loading.
Our previous research has shown that changes in solar
radiation, as seen in 11-year solar cycles, influence hu-
man lifespan [22]. The Sun varies in its radiation with
approximately three years of more intense output
(MAX) followed by approximately eight years of less ra-
diation (MIN). We have shown in a study of death re-
cords of over 50 million persons in the USA that
lifespan is decreased by 1.7 years on average in persons
born and likely conceived at MAX of solar cycles [23].
We proposed that this finding may be due to the in-
creased exposure of our genome to ultraviolet radiationFigure 1 Examples of [max - min] for increasing and decreasing ultra
for non-diabetics and diabetics.(UVR), the most DNA-damaging wavelength reaching
the Earth’s surface [24]. In our previously reported re-
search we found that metabolic diseases, like diabetes,
were suppressed during solar MAX relative to MIN;
conversely, we found that major mental illness was more
likely in those born during solar MAX [25,26]. In this
paper we specifically investigate the modulation of life-
span of persons with type-2 diabetes with changes in the
11-year solar radiation cycle and seasonal variations in
UVR.
Results
We consider [MAX - MIN] for lifespan a metric for sensi-
tivity (for example, responsiveness) to long-term changes
in UVR. Figure 1 shows that the difference in lifespan
between MAX and MIN is less in diabetes than in non-
diabetics. In addition, ethnic minorities have a higher sen-
sitivity, for example, a greater difference between MAX
and MIN, than the white race. Also, females are generally
less sensitive than males in their respective racial groups.
Figure 2 (for males) and Figure 3 (for females) are exam-
ples from a single bimonthly period (March and April)
plotting the difference between diabetic and non-diabetic
lifespan at MAX versus at MIN for all racial groups. Note
that the white and white Canadian group diabetic females
in Figure 3 had a shorter lifespan than non-diabetics. This
is similar to what we would see in today’s environment of
surfeit in contrast to the ethnic minorities born largely
before 1945.violet radiation (uvr) at conception by gender and by racial group
Figure 2 Example of male diabetic lifespan minus male non-diabetic lifespan at max versus min (in years) for various races in March
and April conceptions.
Figure 3 Example of female diabetic lifespan minus female non-diabetic lifespan at max versus min (in years) for various races in
March and April conceptions. [See Appendix 2 in Additional file 1]. Dotted line is equipoise between the Y and X axis for reference.
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Table 2 for MIN, the average years gained for males at
MAX with increasing seasonal light at conception is
greater than with decreasing seasonal light, and although
there is more variation with females at MAX, there is lit-
tle difference between the averages at increasing or de-
creasing light. At MIN however, males gain significantly
more years above females when conceived in decreasing
light.
Data in Tables 1 and 2 for annual years of life gained
are used in calculations resulting in Table 3, and subse-
quently, Table 4 (see Methods). For the convenience of
the reader, month of birth (MOB) is easily converted to
month of conception (MOC) by simply adding three
months to the MOB; for example, a May birth has an
August MOC.
Figure 4 displays the monthly data from Tables 1
and 2 showing that most of the variation in lifespan
occurs at the equinoxes when UVR varies the most
rapidly. Note in Figure 4 that males have a bilobed
pattern for MAX and MIN at the fall equinox while
females have a single lobe. Both males and females
have a single lobe at the spring equinox. The reason
for these differences is not clear. The least variation
in lifespan occurs at the solstices in both genders.
We found that the weighted (72% MIN and 28%











Jan-Feb 1.0663x + 0.0928 (0.9722) 41.4
Feb-Mar 1.3704x + 0.5432 (0.9672) 59.5
Mar-Apr 0.8888x + 0.7059 (0.9771) 43.9
Apr-May 0.9180x + 0.8914 (0.9964) 47.8
May-Jun 0.9499x + 1.0587 (0.9846) 51.5
Jun-Jul 1.067x - 0.3400 (0.9844) 34.9
Jul-Aug 1.0918x - 0.8685 (0.9677) 27.9
Aug-Sep 1.0383x - 0.2481 (0.9913) 35.2
Sep-Oct 1.0019x + 0.1545 (0.9820) 39.9
Oct-Nov 1.2887x + 0.3252 (0.9787) 53.2
Nov-Dec 0.9303x - 0.1257 (0.9508) 33.0




AVG (SD) years Increasing 46.5 (8.5)
AVG (SD) years Decreasing 37.7 (8.6)
Note: Italics for months with increasing UVR.over male non-diabetics was 6.1 years [see Appendix
2 in Additional file 1], whereas that difference in
females was only 2.3 years. Therefore, diabetic males
gained (6.1 - 2.3 =) 3.8 years over diabetic females on
average.
The complexity of this study is related to several over-
lapping variables that include:
1) UVR intensity and variation→ where variation is
likely more important than intensity in activating
diabetes.
2) Seasons and solar cycles→ where seasons appear
more important than solar cycle variation in
affecting diabetes, but appear to be independent of
vitamin D (see Discussion).
3) Being conceived and likely born before 1945 or after
1945→ nutritional environments change from
poorer nutrition to caloric excess between the two
periods.
4) Diabetics and non-diabetics→ in times of hardship
persons who live longer are more likely to express
diabetes (from aging itself ); in times of plenty
diabetics live shorter lives.
5) Whites and ethnic minorities→ the more melanin,
the more sensitive to changes in solar cycle UVR;
for example, long-term changes are more important












1.1427x + 0.1749 (0.9590) 45.5 Oct-Nov
1.3820x + 1.6371 (0.9902) 76.4 Nov-Dec
1.0967x + 0.3297 (0.9407) 46.1 Dec-Jan
1.2347x - 0.0794 (0.9795) 45.1 Jan-Feb
1.122x - 0.1454 (0.9414) 39.9 Feb-Mar
1.0969x - 0.0983 (0.9213) 39.7 Mar-Apr
0.6996x + 1.5517 (0.9797) 49.5 Apr-May
1.0984x + 0.5254 (0.9656) 49.1 May-Jun
1.0736x + 1.0948 (0.9689) 56.7 Jun-Jul
1.2419x + 1.6821 (0.9228) 71.8 Jul-Aug
0.9222x + 0.0196 (0.9566) 34.9 Aug-Sep











and (R2) at MIN
Integral of MIN
years for MAX
−5.0 to 10.0 (males)
Female diabetics
regression EQ
and (R2) at MIN
Integral of MIN
years for MAX
−5.0 to 10.0 (females)
Month of birth
(All races)
Jan-Feb 0.9117x + 0.0927 (0.9722) 35.6 0.8392x - 0.0337 (0.9590) 31.0 Oct-Nov
Feb-Mar 0.7058x - 0.2250 (0.9672) 23.1 0.7165x - 1.1636 (0.9902) 9.4 Nov-Dec
Mar-Apr 1.0993x - 0.6305 (0.9771) 31.8 0.8577x - 0.1375 (0.9407) 30.1 Dec-Jan
Apr-May 1.0854x - 0.9453 (0.9964) 26.5 0.7933x + 0.1134 (0.9795) 31.4 Jan-Feb
May-Jun 1.0365x - 1.0068 (0.9846) 23.8 0.8391x + 0.2486 (0.9414) 35.2 Feb-Mar
Jun-Jul 0.9225x + 0.4064 (0.9844) 40.7 0.8399x + 0.2315 (0.9213) 35.0 Mar-Apr
Jul-Aug 0.8864x + 0.9662 (0.9677) 47.7 0.9144x + 0.0114 (0.9655) 34.5 Apr-May
Aug-Sep 0.9547x + 0.2916 (0.9913) 40.2 0.8791x - 0.3822 (0.9656) 27.2 May-Jun
Sep-Oct 0.9801x - 0.0377 (0.9820) 36.2 0.9026x - 0.9296 (0.9689) 19.9 Jun-Jul
Oct-Nov 0.7594x - 0.1394 (0.9787) 26.4 0.7431x - 1.1432 (0.9228) 10.7 Jul-Aug
Nov-Dec 1.022x + 0.4609 (0.9508) 45.2 1.0463x - 0.1893 (0.9749) 36.4 Aug-Sep




AVG (SD) years Increasing 30.3 (7.0) 28.7 (9.7)
AVG (SD) years Decreasing 39.9 (7.7) 27.2 (10.2)
Note: Italics for months with increasing UVR.
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variation in UVR; women are more canalized with
regard to caloric retention and are less sensitive.
Table 5 concisely summarizes these relationships.
Discussion
This paper presents evidence that UVR, which varies in
intensity with solar cycles and seasons, modulates the life-
span of type-2 diabetics born before 1945. Using the death
records of approximately 829,000 diabetics born before
1945, we found that ethnic minority diabetics lived signifi-
cantly longer than their non-diabetic minority contempor-
aries. In contrast, in the last decades of the 20th centuryTable 3 Calculations using values from Tables 1 and 2
For the MAX portion of solar cycles Years
Diabetic males at MAX in increasing UVR 241.8
Diabetic males at MAX in decreasing UVR 189.5
Diabetic females at MAX in increasing UVR 253.1
Diabetic females at MAX in decreasing UVR 262.8
For the MIN portion of solar cycles Years
Diabetic males at MIN in increasing UVR 144.0
Diabetic males at MIN in decreasing UVR 195.0
Diabetic females at MIN in increasing UVR 137.0
Diabetic females at MIN in decreasing UVR 128.5Native Americans with a high prevalence of obesity and
diabetes have a shorter lifespan [27]. However, the white
diabetic females born prior to 1945 revealed what we
would expect today, for example, shorter lives most prob-
ably due to vascular complications. We suspect that the
difference in lifespan between whites and ethnic minor-
ities was due to poorer nutrition and hard physical work
in the latter groups; indeed, most of human history was a
continuous struggle to obtain food [28]. Many ethnic mi-
norities had fled from famine in Europe and Asia and took
laborious jobs in the United States, but despite the USA
being ‘a land of plenty’, nutrition was a significant problem
manifested by pellagra (niacin deficiency) at least through
the 1940s [29].
Those with epigenetic alterations to increase metabolic
efficiency and caloric storage would have a survival ad-
vantage in an adverse environment. While the hunter-
gatherers of pre-historical humans generally had ad-
equate nutrition, throughout human history there have
been periodic famines in all continents with, in some
cases, the loss of millions of lives [30-33]. In our study
ethnic minorities, had a modest caloric intake readily
metabolized by hard physical labor [34,35]. As discussed
by Lane, people for the last 6,000 years have struggled to
get something to eat, and even in modern times many in
the world go without adequate nutrition [28]. Obesity
was subsequently less prevalent than in the post 1950 to
the present era.
Table 4 Calculations using values from Table 3
For decreasing UVR at
conception
Ratio years gained at MAX by male
diabetics/female diabetics
189.5/ 262.8 = 0.72
Ratio years gained at MIN by male
diabetics/female diabetics
195.0/ 128.5 = 1.52
For increasing UVR at
conception
Ratio years gained at MAX by male
diabetics/female diabetics
241.8/ 253.1 = 0.96
Ratio years gained at MIN by male
diabetics/female diabetics
144.0/ 137.0 = 1.05
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effects that modulate the adult expression of disease. We
hypothesize that rapidly changing UVR is most influen-
tial at conception/early gestation, particularly at the
equinoxes, and alters epigenetic expression in diabetes.
Rapidly decreasing UVR at conception, for example, at
the autumnal equinox, was disadvantageous to the white
race (and those in other races of higher social status)
possibly because of good nutrition and less physically
demanding jobs where activation of ‘frugal’ epigenes
only predisposes to obesity [36]. Women in general are
at a particular disadvantage probably due to a canalized
tendency to retain weight for pregnancy and due to the
effect of estrogens; however, rapidly increasing UVR at
conception, for example, at or around the vernal equi-
nox, may be beneficial to women due to the suppression
of a calorie-conservative epigenome and may also beFigure 4 Trend lines of integral years gained by gender at max and m
year 1945. poly, 3rd degree polynomial trend lines of data from Tables 1 auseful to men who are genetically predisposed to be-
come overweight or who are underactive. A Ukrainian
study has recently showed that type 2 diabetes is more
common in those born in April (for example, conception
in July with decreasing UVR), and is less common in
those born in November and December (for example,
conception in February and March with increasing
UVR) [37].
The above observations suggest that increased skin
melanin is associated with an increased sensitivity to
ambient UVR as seen in Figure 1. One might have
expected the reverse. However, melanin is an adaptation
to increased UVR intensity, and more sensitivity to any
variation in UVR may be necessary and encoded in the
human genome over millennia [24].
One can speculate about how UVR affects an embryo
in utero without direct exposure to UVR. A comprehen-
sive review of how the skin senses the environment was
recently published [38]. With the skin sharing an ectoder-
mal origin with the central nervous system, it is not sur-
prising to find shared neuroregulatory compounds in
both tissues, including serotonergic, melatoninergic,
catacholinergic, opioidergic, and the hormone vitamin D,
among several others. Circulating inflammatory cytokines,
chemokines, photo-oxidation products, and nitric oxide
may also play a role [39-41].
There are recent reports that hypovitaminosis D is
associated with a higher incidence of diabetes [42-44].
This is especially true for those with more skin pig-
mentation [45]. Those persons working in agrarian
jobs would spend much more time outdoors, and by
increasing their vitamin D level, could mitigate orin by months of conception for diabetics who were born before
nd 2 for male and female diabetics.
Table 5 Summary of findings related to ultraviolet radiation (uvr) variations
Lower sensitivity (smaller MAX - MIN) Higher sensitivity (larger MAX - MIN)
Diabetics Non-diabetics
More genetic More epigenetic
White race Ethnic minority races
Ethnic minority diabetics Ethnic minority non-diabetics
Female ethnic minority diabetics Male ethnic minority diabetics
Diabetic females less affected by seasonal changes in UVR, slightly benefit
at MAX
Diabetic males benefit by decreasing seasonal UVR at conception, and
at MIN
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ports adequate vitamin D increasing insulin sensitivity
[46]. This may be an additional reason for the greater
lifespan of those with diabetes around the turn of the
last century as well as greater physical activity and
less obesity. Vitamin D is important in modifying a
human epigenome involved with many adult disorders
[47]. However, as Figure 4 shows, in this study of our
cohort of diabetics there is no difference between the
summer and winter solstice in added life years and
the major variation in lifespan occurs at the equi-
noxes. Any effect of vitamin D on lifespan would
therefore extend beyond the annual seasonal cycle.
Variations in food supply occurring cyclically over
years, would give a survival advantage to those indi-
viduals with an increased ability to store calories and
vitamin D in adipose tissue.
The heterogeneity of our sample results in some persons
that benefit, and some who are harmed, by activating or
suppressing the metabolically sensitive epigenome, as is
evident in Figure 4. Table 5 summarizes observations from
Tables 1 and 2.
We are aware that type-2 diabetes is a heteroge-
neous disease affecting many organ systems and con-
tributing to death in a various ways. However, we
wanted to study specifically how UVR affects lifespan,
not any other clinical aspects of this disease. Separat-
ing the effects of long-term solar-cycle radiation from
that of seasonal (annual) radiation was challenging.
We also probably did not detect more than one-third
of the diabetics in our database, but for those who
were captured, diabetes must have played a significant
role to be entered on a death certificate, and there-
fore, these cases were likely to be the most severe.
We do not have comparable death data of persons
who were born and died post-1945, and another half-
century will pass before that data are available. However,
it is already clear that there is an epidemic of type-2 dia-
betes worldwide. Women are particularly adversely af-
fected in our current environment [48,49]. As we have
shown, diabetic white women were losing lifespan even
before 1945. Some of these findings are obviously due to
a rising standard-of-living in highly developed countries,for example, better food supplies and an increased use
of mechanical devices in lieu of manual labor.
Reports suggest that white race northern Europeans
may have developed a partial resistance to diabetes over
the centuries, becoming adapted to a lactose-rich diet
through farming/animal husbandry, and to rapidly chan-
ging light at higher latitude through natural selection
[50,51].
Migration is probably another important factor in the
increasing incidence of type-2 diabetes. People who are
indigenous to a high-intensity, low-variation photonic
environment, like those born near or on the Equator,
who then migrate to higher latitude, may be more sus-
ceptible to the trigger of decreasing UVR at conception
(especially at the autumnal equinox), and along with a
nutrient-rich lifestyle, more readily acquire type-2 dia-
betes. This may explain, in part, the increased prevalence
of type-2 diabetes in immigrants to northern Europe and
to North America [52]. Once adjusted for ethnicity and
socio-demographic variables, migration alone may not
be crucial to health outcomes [53]. This opens the possi-
bility that other factors, yet to be fully studied, like solar
cycle variations of UVR and geomagnetic forces, modu-
late our epigenome [54].
One way of prospectively confirming the hypothesis in
this paper would be to use ‘knockout’ mice predisposed
to diabetes and see if increasing or decreasing UVR ex-
posure in the early days of gestation (for mice, possibly
as little as a 2-day exposure out of a 19-day gestation) to
see if the expression of diabetes occurs earlier or later in
the animal’s lifetime. Using UVR to treat humans with a
genetic predisposition to diabetes must await the results
of prospective animal studies along with an increased
knowledge of our epigenome [55].
Conclusions
The significant findings of this research are summarized
as follows:
 The effects of UVR modulate human lifespan in
diabetics; for example, both solar and seasonal cycles
affect the human epigenome. We believe that UVR
has a more profound effect at conception/ early
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weakly as in seasonal affective disorder when an
increased appetite and weight gain can be a problem.
 The difference between lifespan at MAX and MIN
serves as a surrogate for sensitivity (or
responsiveness) to long-term variation in UVR. The
differences in lifespan between months would
analogously apply for short-term variation.
 Ethnic minority diabetics, who were born before the
year 1945, lived slightly longer than non-diabetics of
the same period. Our data analysis supports the
hypothesis that epigenetic effects that conserve energy
benefit survival in persons living with marginal
nutrition and exposed to hard physical labor.
 Diabetic women have canalized metabolic
conservation more effectively than men, primarily
for fertility/pregnancy, and are less affected by UVR
than men, but consequently are more susceptible to
weight gain in times of surfeit.
 The hypothesis that we might modulate the
phenotypic expression of type-2 diabetes by using
UVR; for example, optogenetics, is eminently testable.
 Other forces associated with our variable star, like
geomagnetic fields, may also be playing a role in
modulating our epigenome and are areas for future
research.Methods
Data
Data were obtained from the National Center for Health
Statistics (NCHS) for deaths in all 50 states and the Dis-
trict of Columbia from 1979 to 2005 - a total of
58,733,243 deaths. The data were de-identified to preserve
confidentiality with only month and year of birth
obtained. Data used in this study included sex, state of
birth, date of birth (month and year), date of death
(month and year), and race. Since data on Hispanic origin
was not recorded from 1979 to 1988, race categories used
for this study included white, African-American, Native-
American/Alaska Native, Asian/Pacific Islander races.
White Canadians in the study were born in Canada but
lived and died in the United States. From 1989 to 2005 we
had access to a Mexican (Hispanic) cohort. These were
persons born largely in Mexico but lived and died in the
United States. For this study the white race (N =
50,778,214) was the largest group. The sample contained
51% males and 49% females. Approximately 90% of the
persons in the database were born in or before the year
1945 and would have died between 1979 and 2005. The
average age at death was 71. We did not age match con-
trols, but given the sample size, and by randomization, we
derived a reasonable control set. The persons in our data-
base lived in challenging times, which included a GreatDepression occurring between two World Wars in an
agrarian/ industrial economy.
Solar data
The Sun is a variable star which varies its electromag-
netic and plasma energy output in an approximate 11-
year cycle (varying 9 to 14 years). A measure of this en-
ergy output is the sunspot number. Sunspots are mag-
netic storms on the Sun’s surface that indicate increased
fusion activity and their number correlates positively
with the intensity of solar radiation including ultraviolet
wavelengths. UVR is an important source of Earth’s en-
ergy and despite that only 1 percent of the sun’s energy
is emitted at UVR wavelengths between 200 and 300
nm, UVR accounts for nearly 20 percent of the variation
in total irradiance. A recent study revealed that a 5%
variation in ground-level UVR (though not related to
solar cycles) produces a 24% variation in effects on DNA
[56-59]. The average annual number of sunspots was
collected from the NOAA (National Oceanic and At-
mospheric Administration) Web site and the three MAX
years (approximately 28%) of each of the past twelve cy-
cles was obtained to be compared with the remaining
MIN years (approximately 72%) [60]. The average annual
sunspot number for the past 250 years was found to be
49; for the past 60 years the average is 107.5; for the
most powerful cycles (sunspots >135), the average is
154, about three times the 250-year average. The time
period of our study comprised 13 solar cycles [25].
Statistical methodology
Birth year data were grouped by solar MAX or MIN and
were defined as follows: the year before and the year after
the peak years were defined as the Maximum Solar Period
(MAX); the years before and after each three-year MAX
cycle were grouped as Minimum Solar Period (MIN). We
selected diabetics using ICD-9 codes recorded as cause of
death. Total diabetics plus non-diabetics equaled approxi-
mately 54 million, of which 28% were in the MAX group,
which equaled approximately 15 million cases Diabetics
accounted for 1.5% of the total all-racial set, and those
born in a MAX period accounted for 226,442 diabetics.
These were matched with an equal number of randomly
selected non-diabetics for further analysis, serving as con-
trol. Table 6 is an example of the white race from
Additional file 2: Appendix 1 (Table S1 -S6) and gives life-
span statistics for diabetics and non-diabetics by bi-
monthly groups. Table 7 lists the statistics of each racial
group. Table 8 lists the total of diabetics and non-diabetics
by racial group.
In this paper we report both birth and conception
months and we consider the month of conception to be
10 months (approximately 39 weeks) earlier than birth
month. We frequently refer to conception months as we
Table 6 Displays an example from Additional file 2: Appendix 1 for two bimonthly periods for increasing UVR at
conception and for decreasing UVR at conception for the white race (a similar analysis was done for all 12 bimonthly
sets for each racial group
White Average MAX-MIN Average MAX-MIN
July-August Births (years) November-December Births (years)
All male −3.167 −3.141
(White) avga age MAX: avg age MAX:
Non-diabetic 67.4 67.8
avg age at MIN: avg age at MIN:
70.6 71.0
n max = 815,000 n max = 756,000
n min = 795,000 n min = 726,000
standard error = 0.03 standard error = 0.03
p <0.0001 p <0.0001
All female −2.479 −2.360
Non-diabetic avg age MAX: avg age MAX:
74.7 75.2
avg age at MIN: avg age at MIN:
77.2 77.5
n max = 759,000 n max = 708,000
n min = 796,000 n min = 730,000
standard error = 0.03 standard error = 0.03
p <0.0001 p <0.0001
Diabetic male −2.610 −2.057
avg age MAX: avg age MAX:
68.7 69.6
avg age at MIN: avg age at MIN:
71.3 71.6
n max = 9,756 n max = 9,117
n min = 9,783 n min = 9,150
standard error = 0.19 standard error = 0.20
p <0.0001 p <0.0001
Diabetic female −2.074 −1.789
avg age MAX: avg age MAX:
73.6 74.0
avg age at MIN: avg age at MIN:
75.4 75.8
n max = 11,493 n max = 11,053
n min = 12,391 n min = 11,936
standard error = 0.16 standard error = 0.17
p <0.0001 p <0.0001
Equivalent months of conception OCT-NOV (decreasing UVR) FEB-MAR (increasing UVR)
aavg, average; abbr, abbreviation defined
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Table 7 Sample total by race
Race Count Percent Mean age SD Median age
White 45,714,048 84.1 71.9 18.6 76
White (Canadian) 450,760 0.8 78.5 13.4 81
African-American 6,747,125 12.4 62.1 23.1 67
Asian 672,286 1.2 66.2 22.3 72
Native American 249,169 0.5 57.3 24.5 62
Hispanic (Mexican) 532,151 1.0 63.4 23.3 69
Totals 53,914,779 100 70.5 75
Table 8 Total diabetics and non-diabetics by racial group
Race Count of diabetics Count of non-diabetics
White 646,808 45,070,000
African-American 146,598 6,600,290
Native American 6,951 242,208
Asian 9,903 662,383
White Canadian 5,766 444,993
Mexican 12,705 519,430
Totals 828,731 53,539,304a
aThe totals in Tables 7 and 8 do not agree by 0.84% due to the fact that in
some cases diagnosis was not recorded.
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of environmental UVR than at the time of birth.
Data analysis
We subtracted the age-at-death of non-diabetics from the
age-at-death of diabetics for all races for months of con-
ception (10 months earlier than months of birth), and for
both genders for MAX and MIN of solar cycles. These
data, derived from Additional file 2: Appendix 1 (which
only shows a single bimonthly sample out of a full year of
data), are displayed in Additional file 1: Appendix 2 [see
Table S1-S6]. The data from Additional file 1: Appendix 2
were then plotted for each set of months (bimonthly to in-
crease N), MAX on the Y-axis, MIN on the X-axis (see
Figures 2 and 3). Regression equations were calculated by
Excel and were integrated with Mathematica version 7.0
from −5.0 to 10.0 years (a reasonable range seen in the
regressions) to calculate the overall number of years of life
gained (or lost) by diabetics over non-diabetics. We
performed this procedure for both MAX and MIN (by re-
versing the axes) and the results of lifespan years gained
or lost are displayed in Tables 1 and 2 in the 3rd and 5th
columns. The high R2 (all 24 equations, 12 for MAX and
12 for MIN, was >0.90) suggests a strong relationship
between radiant energy at MAX and MIN and the lifespan
difference between diabetics and non-diabetics. The inte-
grals of the linear regression lines from Tables 1 and 2
were plotted on the Y-axis with months of conception on
the X-axis, for MAX and MIN and for males and females
as shown in Figure 4.
When months of the year with increasing light are
compared with those months with decreasing at both
MAX and MIN, we must take into account that the sol-
stices occur about 10 days (approximately 16% of a two-
month period) before the end of the month. Further cal-
culations were performed using the data from Tables 1
and 2, an example of which follows for the MAX portion
of solar cycles:
Diabetic Males at MAX in increasing UVR: (0.16)
(Dec-Jan) + (Jan-Feb) + (Feb-Mar) + (Mar-Apr) + (Apr-
May) + (0.84) (May-Jun) = (0.16) (37.1) + (41.4) + 59.5 +
43.9 + 47.8 + (0.84) (51.5) = 241.8 yearsThe Table 3 summarizes calculations of integral years
gained by diabetics. Table 4 shows the calculations using
the data in Table 3.
Since MIN comprises approximately 72% of a solar
cycle and MAX approximately 28%, then a weighted
average using values from Table 4:
Male /Female diabetic ratio = (0.72) (1.52) + (0.28)
(0.72) = 1.09 + 0.20 = 1.30 for decreasing UVR
Similarly,
Male/ Female diabetic ratio = (0.72) (1.05) + (0.28)
(0.96) = 0.76 + 0.27 = 1.02 for increasing UVR
Therefore, the male/female ratio of years gained by
diabetics in decreasing UVR/ increasing UVR = 1.30/
1.02 = 1.27
Note that the above ratios indicate relative effects and
do not translate directly to differences in lifespan as
measured in years.Ethics statement
As the data obtained were de-identified, and as there
were no direct therapeutic interventions of persons, we
declare no ethical conflicts in our study.Study strengths
The large death records database from the entire United
States gives high statistical power. We did not have to
use life expectancy tables as we had the actual time of
birth and death of each case.
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The use of death certificates by the database for diagnosis
is a limitation in this study. However, as stated previously,
those listed as diabetic were the most seriously afflicted so
the diagnosis would probably not be in doubt. The small
number of type-1 diabetics (usually approximately 5 to
10%) mixed in the sample would not significantly alter our
conclusions.
How this study contributes to new knowledge
We believe this study supports the effect of UVR in
modulating the human epigenome in type-2 diabetes.
Additional files
Additional file 1: Appendix 2 (A): RESULTS for MALES of Step 1 in
Sequence of analysis [diabetic minus non-diabetic lifespan]. MOC =
month of conception; MOB = month of birth. (B): RESULTS for FEMALES
of Step 1 in Sequence of analysis [diabetic minus non-diabetic lifespan].
MOC = month of conception; MOB = month of birth.
Additional file 2: Appendix 1. Table S1 [MAX – MIN] for White Non-
diabetics & Diabetics by Increasing or Decreasing light at Birth (or
Conception). Table S2: [MAX – MIN] for Asian Non-diabetics & Diabetics
by Increasing or Decreasing light at Birth (or Conception). Table S3:
[MAX – MIN] for White (Canadian) Non-diabetics & Diabetics by
Increasing or Decreasing light at Birth (or Conception). Table S4: [MAX –
MIN] for Hispanic Non-diabetics & Diabetics by Increasing or Decreasing
light at Birth (or Conception). Table S5: [MAX – MIN] for African-
American Non-diabetics & Diabetics by Increasing or Decreasing light at
Birth (or Conception). Table S6: [MAX – MIN] for Native American Non-
diabetics & Diabetics by Increasing or Decreasing light at Birth (or
Conception).
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